Skip directly to content

Adelaide Manufacturing

The Adelaide site was established in 2003 and joined the Pfizer netowrk following the acquisition of Hospira in 2015. 

The site’s major product is pegfilgrastim used to prevent infection in patients undergoing chemotherapy. 

Adelaide’s almost 100 colleagues are employed across chemistry, biology, quality control, manufacturing and compliance and come from a diverse range of backgrounds with 22 nationalities represented on site.